SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTII - Miscellaneous
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy2/9/2006 7:45:17 AM
   of 1296
 
2006 - Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice.

Almeida RC, Souza DG, Soletti RC, Lopez MG, Rodrigues AL, Gabilan NH.

Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Campus Universitario, Trindade, Florianopolis 88040-900, SC, Brazil.

This study investigated the cellular signaling pathways involved in the acute antidepressant-like action of memantine in the forced swimming test (FST) in mice. The immobility time in the FST was reduced by memantine (3-10mg/kg, i.p.). The anti-immobility effect of memantine (3mg/kg, i.p.) was prevented by pretreatment with H-89 (1mug/site, i.c.v., an inhibitor of PKA), PD098059 (5mug/site, i.c.v., an inhibitor of MAPK/ERK), KN-62 (1mug/site, i.c.v., an inhibitor of CaMKII), but not with chelerythrine (1mug/site, i.c.v., an inhibitor of PKC).

Taken together, these results firstly demonstrate that the acute antidepressant-like effect of memantine seems to be dependent on the cellular signaling modulated by PKA, CaMKII and MAPK/ERK, but not by PKC.

PMID: 16289784 [PubMed - in process]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext